Medical Ikkou Group Co.,Ltd. (TYO:3353)
Japan · Delayed Price · Currency is JPY 2,773.00
0.00 (0.00%)
Oct 22, 2026, 2:53 PM JST
Medical Ikkou Group Ratios and Metrics
Market cap in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 10,443 | 11,486 | 8,276 | 8,775 | 9,727 | 9,578 | |
Market Cap Growth | -0.25% | 38.79% | -5.69% | -9.78% | 1.56% | -15.29% |
Enterprise Value | 13,069 | 15,855 | 10,411 | 12,476 | 13,270 | 13,798 |
Last Close Price | 2773.00 | 2986.35 | 2072.93 | 2139.22 | 2325.80 | 2255.83 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
PE Ratio | 7.16 | 9.01 | 7.30 | 8.45 | 12.82 | 11.24 |
PS Ratio | 0.19 | 0.21 | 0.17 | 0.22 | 0.29 | 0.28 |
PB Ratio | 0.63 | 0.70 | 0.56 | 0.63 | 0.77 | 0.80 |
P/TBV Ratio | 0.69 | 0.78 | 0.63 | 0.71 | 0.92 | 0.99 |
P/FCF Ratio | 5.83 | 16.84 | 40.97 | 2.21 | 9.77 | 11.78 |
P/OCF Ratio | 4.77 | 9.51 | 6.91 | 2.05 | 7.44 | 8.44 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
EV/Sales Ratio | 0.23 | 0.29 | 0.22 | 0.31 | 0.39 | 0.41 |
EV/EBITDA Ratio | 4.78 | 6.03 | 4.24 | 5.33 | 7.47 | 6.43 |
EV/EBIT Ratio | 7.01 | 8.87 | 6.15 | 8.00 | 14.19 | 10.82 |
EV/FCF Ratio | 7.30 | 23.25 | 51.54 | 3.14 | 13.32 | 16.97 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Debt / Equity Ratio | 0.57 | 0.63 | 0.68 | 0.69 | 0.72 | 0.95 |
Debt / EBITDA Ratio | 3.46 | 3.94 | 4.08 | 4.09 | 5.13 | 5.27 |
Debt / FCF Ratio | 5.28 | 15.20 | 49.58 | 2.41 | 9.15 | 13.91 |
Net Debt / Equity Ratio | 0.12 | 0.26 | 0.22 | 0.14 | 0.21 | 0.28 |
Net Debt / EBITDA Ratio | 0.71 | 1.61 | 1.32 | 0.80 | 1.51 | 1.55 |
Net Debt / FCF Ratio | 1.09 | 6.22 | 16.08 | 0.47 | 2.68 | 4.08 |
Asset Turnover | 1.49 | 1.53 | 1.47 | 1.35 | 1.20 | 1.17 |
Inventory Turnover | 21.19 | 21.20 | 21.50 | 23.72 | 25.16 | 25.97 |
Quick Ratio | 1.31 | 1.25 | 1.22 | 1.32 | 1.54 | 1.53 |
Current Ratio | 1.67 | 1.65 | 1.54 | 1.61 | 1.78 | 1.73 |
Return on Equity (ROE) | 9.41% | 8.46% | 8.03% | 8.17% | 6.29% | 7.75% |
Return on Assets (ROA) | 3.09% | 3.11% | 3.21% | 3.29% | 2.07% | 2.77% |
Return on Invested Capital (ROIC) | 6.25% | 6.02% | 6.06% | 6.54% | 3.60% | 4.91% |
Return on Capital Employed (ROCE) | 7.40% | 6.90% | 7.50% | 7.30% | 4.70% | 6.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Earnings Yield | 13.97% | 11.10% | 13.69% | 11.84% | 7.80% | 8.90% |
FCF Yield | 17.15% | 5.94% | 2.44% | 45.30% | 10.24% | 8.49% |
Dividend Yield | 4.33% | 3.93% | 2.73% | 1.93% | 1.54% | 1.57% |
Payout Ratio | 30.91% | 29.49% | 16.50% | 14.44% | 19.76% | 17.61% |
Buyback Yield / Dilution | -0.10% | -0.10% | -0.07% | -0.03% | -0.02% | 0.45% |
Total Shareholder Return | 4.23% | 3.83% | 2.66% | 1.90% | 1.53% | 2.02% |